MTEK vs AMBA vs SLAB vs AXON

For growth investors, Maris-Tech Ltd.

(MTEK) is the stronger pick with 50. 8% revenue growth year-over-year, versus 25. 8% for Ambarella, Inc. (AMBA). Axon Enterprise, Inc. (AXON) offers the better valuation at 282. 7x trailing P/E (55. 0x forward), making it the more compelling value choice. Analysts rate Ambarella, Inc. (AMBA) a "Buy" — based on 36 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Axon Enterprise, Inc.

is actually cheaper at 55. 0x.

Over the past 5 years, Axon Enterprise, Inc.

(AXON) delivered a total return of +216. 8%, compared to -62. 5% for Maris-Tech Ltd. (MTEK). Over 10 years, the gap is even starker: AXON returned +22. 0% versus MTEK's -62. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Axon Enterprise, Inc.

(AXON) is the lower-risk stock at 1. 19β versus Ambarella, Inc. 's 2. 53β — meaning AMBA is approximately 112% more volatile than AXON relative to the S&P 500. On balance sheet safety, Ambarella, Inc. (AMBA) carries a lower debt/equity ratio of 1% versus 59% for Axon Enterprise, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Maris-Tech Ltd.

(MTEK) is pulling ahead at 50. 8% versus 25. 8% for Ambarella, Inc. (AMBA). On earnings-per-share growth, the picture is similar: Silicon Laboratories Inc. grew EPS 66. 6% year-over-year, compared to -68. 5% for Axon Enterprise, Inc.. Over a 3-year CAGR, MTEK leads at 43. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Axon Enterprise, Inc.

(AXON) is the more profitable company, earning 4. 5% net margin versus -41. 1% for Ambarella, Inc. — meaning it keeps 4. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MTEK leads at 22. 2% versus -44. 4% for AMBA. At the gross margin level — before operating expenses — AMBA leads at 60. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Axon Enterprise, Inc.

(AXON) trades at 55. 0x forward P/E versus 95. 4x for Ambarella, Inc. — 40. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AXON: 70. 2% to $726. 71.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Silicon Laboratories Inc.

(SLAB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 25), +375. 0% 10Y return). Maris-Tech Ltd. (MTEK) carries a higher beta of 2. 25 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SLAB: +375. 0%, MTEK: -62. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MTEK (Technology) and AMBA (Technology) and SLAB (Technology) and AXON (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.